These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34294273)

  • 21. Long term outcomes of new generation drug eluting stents versus coronary artery bypass grafting for multivessel and/or left main coronary artery disease. A Bayesian network meta-analysis of randomized controlled trials.
    Mina GS; Watti H; Soliman D; Shewale A; Atkins J; Reddy P; Dominic P
    Cardiovasc Revasc Med; 2018 Sep; 19(6):671-678. PubMed ID: 29396239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review.
    Deb S; Wijeysundera HC; Ko DT; Tsubota H; Hill S; Fremes SE
    JAMA; 2013 Nov; 310(19):2086-95. PubMed ID: 24240936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of percutaneous coronary intervention with drug eluting stents versus coronary artery bypass grafting in patients with multivessel coronary artery disease: Meta-analysis of six randomized controlled trials.
    Fanari Z; Weiss SA; Zhang W; Sonnad SS; Weintraub WS
    Cardiovasc Revasc Med; 2015 Mar; 16(2):70-7. PubMed ID: 25662779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis.
    Giacoppo D; Colleran R; Cassese S; Frangieh AH; Wiebe J; Joner M; Schunkert H; Kastrati A; Byrne RA
    JAMA Cardiol; 2017 Oct; 2(10):1079-1088. PubMed ID: 28903139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hybrid Revascularization: A Review.
    Saha T; Naqvi SY; Goldberg S
    Cardiology; 2018; 140(1):35-44. PubMed ID: 29734170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous coronary intervention compared with coronary artery bypass graft in coronary artery disease patients with chronic kidney disease: a systematic review and meta-analysis.
    Ren X; Liu W; Peng Y; Li Q; Chai H; Zhao ZG; Meng QT; Chen C; Zhang C; Luo XL; Chen M; Huang DJ
    Ren Fail; 2014 Sep; 36(8):1177-86. PubMed ID: 24986458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous intervention versus coronary artery bypass graft surgery in left main coronary artery stenosis: a systematic review and meta-analysis.
    Zhang XL; Zhu QQ; Yang JJ; Chen YH; Li Y; Zhu SH; Xie J; Wang L; Kang LN; Xu B
    BMC Med; 2017 Apr; 15(1):84. PubMed ID: 28427392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic review of cost-effectiveness of percutaneous coronary intervention vs. surgery for the treatment of multivessel coronary artery disease in the drug-eluting stent era.
    Ariyaratne TV; Yap CH; Ademi Z; Rosenfeldt F; Duffy SJ; Billah B; Reid CM
    Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):261-270. PubMed ID: 29474722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Everolimus Eluting Stents Versus Coronary Artery Bypass Graft Surgery for Patients With Diabetes Mellitus and Multivessel Disease.
    Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
    Circ Cardiovasc Interv; 2015 Jul; 8(7):e002626. PubMed ID: 26156152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents in patients with multivessel coronary artery disease compared to coronary artery bypass surgery five-years after intervention.
    Krenn L; Kopp C; Glogar D; Lang IM; Delle-Karth G; Neunteufl T; Kreiner G; Kaider A; Bergler-Klein J; Khorsand A; Nikfardjam M; Laufer G; Maurer G; Gyöngyösi M
    Catheter Cardiovasc Interv; 2014 Dec; 84(7):1029-39. PubMed ID: 24403120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of acute coronary syndromes in patients with diabetes: implications of the FREEDOM trial.
    Burgess SN; Mussap CJ; French JK
    Clin Ther; 2013 Aug; 35(8):1069-75. PubMed ID: 23973040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Meta-Analysis Comparing Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Unprotected Left Main Disease.
    Kodumuri V; Balasubramanian S; Vij A; Siddamsetti S; Sethi A; Khalafallah R; Khosla S
    Am J Cardiol; 2018 Apr; 121(8):924-933. PubMed ID: 29502793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current Use and Trends in Unprotected Left Main Coronary Artery Percutaneous Intervention.
    Nagarajarao HS; Ojha CP; Mulukutla V; Ibrahim A; Mares AC; Paul TK
    Curr Cardiol Rep; 2020 Feb; 22(4):16. PubMed ID: 32036460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left main coronary artery disease: importance, diagnosis, assessment, and management.
    Ragosta M
    Curr Probl Cardiol; 2015 Mar; 40(3):93-126. PubMed ID: 25765453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Term Mortality After Coronary Revascularization in Nondiabetic Patients With Multivessel Disease.
    Chang M; Ahn JM; Lee CW; Cavalcante R; Sotomi Y; Onuma Y; Tenekecioglu E; Han M; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    J Am Coll Cardiol; 2016 Jul; 68(1):29-36. PubMed ID: 27364047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study of bypass versus percutaneous intervention for left main disease.
    Slim M; Meddeb MA; Neffati E; Ghardallou H; Lagren A; Tarmiz A; Kortas C; Gribaa R; Boughzela E
    Tunis Med; 2019 Apr; 97(4):533-540. PubMed ID: 31729703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients.
    Palmerini T; Serruys P; Kappetein AP; Genereux P; Riva DD; Reggiani LB; Christiansen EH; Holm NR; Thuesen L; Makikallio T; Morice MC; Ahn JM; Park SJ; Thiele H; Boudriot E; Sabatino M; Romanello M; Biondi-Zoccai G; Cavalcante R; Sabik JF; Stone GW
    Am Heart J; 2017 Aug; 190():54-63. PubMed ID: 28760214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trial.
    Abdallah MS; Wang K; Magnuson EA; Spertus JA; Farkouh ME; Fuster V; Cohen DJ;
    JAMA; 2013 Oct; 310(15):1581-90. PubMed ID: 24129463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: a comparison of fractional flow reserve-guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with multivessel coronary artery disease.
    Zimmermann FM; De Bruyne B; Pijls NH; Desai M; Oldroyd KG; Park SJ; Reardon MJ; Wendler O; Woo J; Yeung AC; Fearon WF
    Am Heart J; 2015 Oct; 170(4):619-626.e2. PubMed ID: 26386784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.